Due to macrophage-specific localization of CHIT1 in remodeled airways of fatal asthma patients, we chose a 7-week-long HDM administration when alveolar macrophage accumulation (CD11cpos and SiglecFpos) was significantly induced (Figure 2B,C). The gene discussed is CHIT1; the disease is asthma.